priate indexes will receive considerable attention regardless of the magnitude of its primary readership. It is thus important to note that the Yale Journal is listed in all major indexes and abstract services.
If this seems like an attempt to attract first-rate papers, it is! As long as the Yale Journal continues to pursue an uncompromising policy of critical review, with consequent rejection of inadequate papers, it will remain a prestigious medium through which to reach the scientific public. An investigator who wants to reach a broad medical and scientific audience without sacrificing dissemination of his data, would do well to submit his efforts here.
Clearly, the Yale Journal need not rely upon preclinical scientific articles, since there is an abundance of clinical information at Yale and other medical institutions. Medical, surgical, and pediatric ground rounds are frequently scholarly reviews of pathophysiology and therapy, and clinical pathology conferences, still the mainstay of the New England Journal of Medicine, deserve a place in the Yale Journal, too. Carefully documented case reports and more extensive clinical investigations can be the scientific equal of experiments with rodents and are equally desirable for these pages. We have also recently reinstituted coverage of events around the Yale medical community, including abstracts of important talks by many visiting scientists. A series of articles on medical aspects of ecology, such as the importance of trees and marshlands in preventing poisoning by serving as "traps" for pollutants, will begin in the fall. Another on comparative medicine, indicating the similarity of naturally-occurring and experimentally-induced diseases of animals to human afflictions, is also projected. Lest this cause anxiety about changing the "tone" of the Yale Journal, one should review the contents of Volume I, 1928 Volume I, -1929 I did recently. Most of the articles were clinical investigations or descriptions of unusual cases, interspersed with medical history, community health, and one article on "Colour Vision of Fish". Many of the "great names" at Yale were represented in its 391 pages (October through July) including Trask, Stone, Hiscock, Harvey, Blake, d'Herelle, Burr, and Cowgill, not to mention "Vernon William Lippard, of the fourth-year class, ... who was elected to Alpha Omega Alpha", as noted under Comments (Events).
The Yale Journal must continue to evolve as it has throughout its 48-year history, in order to cope with changes in the medical environment. Yet, plus ca change, plus c'est la me^me chose! The expanded faculty and student editorial staff and I hope to foster the best features of the Journal in order to maintain its viability. With the help of the Yale medical community and scientists at our sister institutions, both as contributors and subscribers, we hope to keep this honorably and determinedly unspecialized journal of medical science afloat amidst the many other journals of evernarrowing scope.
